The Department of Health on Tuesday (July 13) assured the public that the possibility of those inoculated with the Johnson & Johnson COVID-19 vaccine acquiring a “rare nerve disorder” “remains very low.”
This assurance came following the U.S. Food and Drug Administration warning that Janssen vaccine recipients may experience an increased risk of Guillain-Barré Syndrome (GBS) during the 42 days following inoculation.
GBS is a rare disorder in which the body’s immune system attacks the nerves.
DOH Undersecretary Maria Rosario Vergeire in a statement said that GBS is a rare condition and that current data shows that the benefits of vaccination still outweigh the chances of experiencing adverse reactions such as GBS.
Meanwhile, Vergeire said patients should report to their local vaccine operations center should they start experiencing symptoms of GBS.
She added that the medical community must immediately report the suspected reactions to epidemiology and surveillance units for propers investigation and assessment.
Next week, the country will be receiving 3.2 million Johnson & Johnson doses donated by the United States government. –(PTV News)/PG – jlo
Watch full report here:
